The EBMT activity survey report 2017: A focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

Biblos-e Archivo/Manakin Repository

Files in this item

Thumbnail
Share

Delicious Save this on Delicious

Citations

This item appears in the following Collection(s)